Inhibrx Biosciences, Inc. (INBX) insider trading
Over the last 12 months, 3 insiders bought $6.35M and 1 insider sold $279K of Inhibrx Biosciences, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Oct 14, 2026: Lappe Mark bought 10,040 shares ($849K)
- Sep 28, 2026: Lappe Mark bought 10,000 shares ($999K)
- Sep 23, 2026: Kayyem Jon Faiz bought 5,000 shares ($500K)
- Sep 16, 2026: Kayyem Jon Faiz bought 5,000 shares ($500K)
- Sep 15, 2026: Manhard Kimberly sold 1,500 shares ($164K)
- Sep 9, 2026: Manhard Kimberly sold 1,000 shares ($115K)
- Sep 8, 2026: Forsyth Douglas bought 2,500 shares ($287K)
- Sep 8, 2026: Lappe Mark bought 25,000 shares ($2.65M)
- Sep 8, 2026: Kayyem Jon Faiz bought 5,000 shares ($568K)
- Oct 7, 2025: Viking Global Investors Lp sold 350,000 shares ($11.3M)